Link to this page
Multiple sclerosis ontology
Last uploaded:
November 11, 2014
Jump to:
Preferred Name | Prostaglandin_E2 | |
Synonyms |
|
|
ID |
http://scai.fraunhofer.de/MSOntology#Postaglandin_E2 |
|
Context |
MESH :D015232
|
|
isDefinedBy |
The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa.
(Source: http://www.ncbi.nlm.nih.gov/mesh/68015232 )
|
|
prefixIRI |
MSOntology:Postaglandin_E2
|
|
prefLabel |
Prostaglandin_E2
|
|
Synonym |
(5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate Cervidil (TN) BSPBio_001490 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l- Dinoprostone beta-Cyclodextrin Clathrate Minprostin E2 l-Prostaglandin E2 (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic Prostin E2 (TN) Dinoprostonum [INN-Latin] Prostaglandin E2alpha SMP2_000056 (Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid Dinoprostone Gel, Prepidil 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)- Prostarmon E Prostarmon E2 E2alpha, Prostaglandin l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid BMS-279654 & PGE2 5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)- (8CI) Dinoproston P5640_SIGMA alpha, Prostaglandin E2 Dinoprostone Prostaglandin E2 nchembio.106-comp6 (5Z,11-alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Prestwick_793 Dinoprostone (JAN/USP/INN) Prosta-5,13-dien-1-oic acid, (5Z,11-alpha,13E,15S)-11,15-dihydroxy-9-oxo- P0409_SIGMA E2 alpha, Prostaglandin MolPort-003-939-184 alpha, PGE2 IDI1_033960 CHEBI:15551 E2, Prostaglandin (E,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dienoic acid UNII-K7Q1JQR04M Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11alpha,13E,15S)- 05D31BD5-818B-4A92-8CFC-BEC19926A5B3 Minprositin E2 BRD-K26521938-001-04-9 Dinoprostone [USAN:INN:BAN:JAN] nchembio.147-comp12 7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate Prepidil Gel Dinoprostona NCGC00092361-05 NCGC00092361-04 NCGC00092361-01 NCGC00092361-03 NCGC00092361-02 (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Prostaglandin E2 alpha Dinoprostonum (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid P6532_SIGMA (5Z,11.alpha.,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid Prepidil (TN) LMFA03010003 (15S)-Prostaglandin E2 Dinoprostona [INN-Spanish] EINECS 206-656-6 363-24-6 AC-6098 AC1NQWXW
BML1-F07 C00584 CHEMBL548 CID5280360 Cervidil D00079 D015232 DAP000360 DB00917 HMS1361K12 HMS1791K12 HMS1989K12 HMS2089D17 LS-125823 NSC 165560 NSC 196514 PGE2 PGE2 alpha PGE2alpha Prepidil Propess Prostenon Prostin Prostin E Prostin E2 ST50826265 U 12062 U-12062 [3H]PGE2 l-PGE2
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping